Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Neuropharmacology. 2014 May 20;85:91–103. doi: 10.1016/j.neuropharm.2014.05.005

Fig. 11.

Fig. 11

EEG records showing no SWDs in Wistar or ACI rats treated chronically with VU0360172. Wistar or ACI rats (n = 3–6 per group) were treated with VU0360172 (3 mg/kg s.c.) or vehicle twice daily for 8–10 days, and recorded at baseline (day 0) and at the indicated days of treatment. These treatments did not cause the appearance of SWDs in the two strains of rats. Representative EEG recordings of rats treated with VU0360172 are shown.